Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 21;19(1):862.
doi: 10.1186/s12913-019-4721-x.

Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial

Kim A Hoffman  1 , Robin Baker  2 , Lynn E Kunkel  2 , Elizabeth Needham Waddell  2 , Paula J Lum  3 , Dennis McCarty  2 , P Todd Korthuis  2   4
Affiliations

Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial

Kim A Hoffman et al. BMC Health Serv Res. .

Abstract

Background: The CTN-0067 CHOICES trial tests implementation of extended-release naltrexone (XR-NTX) versus treatment-as-usual (TAU) for opioid use disorders (OUD) in HIV clinics to improve HIV viral suppression. The study team investigated recruitment strategies to elucidate the barriers and facilitators to recruitment and enrollment in the study.

Main text: Methods: Semi-structured, in-depth, digitally recorded interviews were completed with study recruitment-related staff and medical providers (n = 26) from six participating HIV clinics in the fall of 2018. Interviews probed 1) factors that might prevent prospective participants from engaging in study recruitment and enrollment procedures and 2) strategies used by study staff that encourage eligible patient participation. Interviews were transcribed and thematically analyzed using a content analysis approach.

Results: All respondents reported that barriers to recruitment and enrollment included challenging patient social and structural factors (e.g., homelessness or living environments with high substance use, criminal justice involvement), difficulty locating patients with unsuppressed HIV viral load and OUD within the HIV clinic, time-consuming study enrollment processes, and stigma around HIV and OUD which inhibited treatment seeking. Some respondents observed that distrust of research and researchers impeded recruitment activities in the community. A specific medication-related barrier was patient fear of opioid abstinence required prior to XR-NTX induction. Facilitators of recruitment included use of trusted peer outreach/recruitment workers in the community, hospitalizations that offered windows of opportunities for screening and XR-NTX induction, providing participant transportation, and partnerships with harm reduction organizations for referrals.

Conclusions: Though study personnel encountered barriers to recruitment in the CHOICES study, persons with untreated HIV and OUD can be enrolled in multisite clinical trials by using enhanced recruitment strategies that extend outside of the HIV clinic. Employing peer outreach workers and collaborating with syringe service programs may be especially helpful in facilitating recruitment and merit inclusion in similar study protocols.

PubMed Disclaimer

Conflict of interest statement

All of the authors are co-investigators on CTN-0067. Alkermes (a global biopharmaceutical company) has donated the extended-release naltrexone used in the study protocol. In addition, Dr. Korthuis serves on a separate investigation using buprenorphine donated by Indivior. Dr. Kim Hoffman is an associated editor for BMC Health Services Research. The remaining authors declare no competing interests.

References

    1. Bertholet Nicolas, Cheng Debbie M., Samet Jeffrey H., Quinn Emily, Saitz Richard. Alcohol consumption patterns in HIV-infected adults with alcohol problems. Drug and Alcohol Dependence. 2010;112(1-2):160–163. doi: 10.1016/j.drugalcdep.2010.05.009. - DOI - PMC - PubMed
    1. Braithwaite R. S., Conigliaro J., Roberts M. S., Shechter S., Schaefer A., McGinnis K., Rodriguez M. C., Rabeneck L., Bryant K., Justice A. C. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19(4):459–466. doi: 10.1080/09540120601095734. - DOI - PMC - PubMed
    1. Chander G, Josephs J, Fleishman JA, Korthuis PT, Gaist P, Hellinger J, Gebo K. Alcohol use among HIV-infected persons in care: results of a multi-site survey. HIV Medicine. 2008;9(4):196–202. doi: 10.1111/j.1468-1293.2008.00545.x. - DOI - PMC - PubMed
    1. Korthuis P. Todd, Fiellin David A., McGinnis Kathleen A., Skanderson Melissa, Justice Amy C., Gordon Adam J., Doebler Donna Almario, Asch Steven M., Fiellin Lynn E., Bryant Kendall, Gibert Cynthia L., Crystal Stephen, Goetz Matthew Bidwell, Rimland David, Rodriguez-Barradas Maria C., Kraemer Kevin L. Unhealthy Alcohol and Illicit Drug Use Are Associated With Decreased Quality of HIV Care. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2012;61(2):171–178. doi: 10.1097/QAI.0b013e31826741aa. - DOI - PMC - PubMed
    1. Korthuis Philip Todd, Josephs Joshua S., Fleishman John A., Hellinger James, Himelhoch Seth, Chander Geetanjali, Morse Elizabeth B., Gebo Kelly A. Substance abuse treatment in human immunodeficiency virus: The role of patient–provider discussions. Journal of Substance Abuse Treatment. 2008;35(3):294–303. doi: 10.1016/j.jsat.2007.11.005. - DOI - PMC - PubMed